These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 17591546)
1. Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity. Grierson JR; Brockenbrough JS; Rasey JS; Wiens LW; Schwartz JL; Jordan R; Vesselle H Nucl Med Biol; 2007 Jul; 34(5):471-8. PubMed ID: 17591546 [TBL] [Abstract][Full Text] [Related]
2. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer. Lee SJ; Yeo JS; Lee HJ; Lee EJ; Kim SY; Jang SJ; Lee JJ; Ryu JS; Moon DH Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1327-35. PubMed ID: 24562648 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. Grierson JR; Schwartz JL; Muzi M; Jordan R; Krohn KA Nucl Med Biol; 2004 Oct; 31(7):829-37. PubMed ID: 15464384 [TBL] [Abstract][Full Text] [Related]
5. Induction of thymidine phosphorylase expression by AZT contributes to enhancement of 5'-DFUR cytotoxicity. Tsuneyoshi K; Haraguchi M; Hongye Z; Gotanda T; Tachiwada T; Sumizawa T; Furukawa T; Baba M; Akiyama S; Nakagawa M Cancer Lett; 2006 Dec; 244(2):239-46. PubMed ID: 16457948 [TBL] [Abstract][Full Text] [Related]
6. Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. Muzi M; Mankoff DA; Grierson JR; Wells JM; Vesselle H; Krohn KA J Nucl Med; 2005 Feb; 46(2):371-80. PubMed ID: 15695799 [TBL] [Abstract][Full Text] [Related]
7. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. van Waarde A; Cobben DC; Suurmeijer AJ; Maas B; Vaalburg W; de Vries EF; Jager PL; Hoekstra HJ; Elsinga PH J Nucl Med; 2004 Apr; 45(4):695-700. PubMed ID: 15073267 [TBL] [Abstract][Full Text] [Related]
8. Thymidine phosphorylase in cancer aggressiveness and chemoresistance. Furukawa T; Tabata S; Yamamoto M; Kawahara K; Shinsato Y; Minami K; Shimokawa M; Akiyama SI Pharmacol Res; 2018 Jun; 132():15-20. PubMed ID: 29604437 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines. Seitz U; Wagner M; Neumaier B; Wawra E; Glatting G; Leder G; Schmid RM; Reske SN Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1174-81. PubMed ID: 12192562 [TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression. Nakajima Y; Madhyastha R; Maruyama M Anticancer Agents Med Chem; 2009 Feb; 9(2):239-45. PubMed ID: 19199868 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluations of a radioiodinated thymidine phosphorylase inhibitor as a tumor diagnostic agent for angiogenic enzyme imaging. Akizawa H; Zhao S; Takahashi M; Nishijima K; Kuge Y; Tamaki N; Seki K; Ohkura K Nucl Med Biol; 2010 May; 37(4):427-32. PubMed ID: 20447553 [TBL] [Abstract][Full Text] [Related]
12. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines. Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463 [TBL] [Abstract][Full Text] [Related]
13. Thymidine phoshorylase as a target for antiangiogenesis treatment. Peters GJ; Bijnsdorp IV; Fukushima M Nucleic Acids Symp Ser (Oxf); 2008; (52):629. PubMed ID: 18776537 [TBL] [Abstract][Full Text] [Related]
14. The role of thymidine phosphorylase and uridine phosphorylase in (fluoro)pyrimidine metabolism in peripheral blood mononuclear cells. Temmink OH; de Bruin M; Laan AC; Turksma AW; Cricca S; Masterson AJ; Noordhuis P; Peters GJ Int J Biochem Cell Biol; 2006; 38(10):1759-65. PubMed ID: 16798057 [TBL] [Abstract][Full Text] [Related]
15. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975 [TBL] [Abstract][Full Text] [Related]
16. 2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9. Nakajima Y; Haraguchi M; Furukawa T; Yamamoto M; Nakanishi H; Tatematsu M; Akiyama S Int J Cancer; 2006 Oct; 119(7):1710-6. PubMed ID: 16646076 [TBL] [Abstract][Full Text] [Related]
17. Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation. Oyama N; Ponde DE; Dence C; Kim J; Tai YC; Welch MJ J Nucl Med; 2004 Mar; 45(3):519-25. PubMed ID: 15001697 [TBL] [Abstract][Full Text] [Related]
18. The role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor behavior. Bijnsdorp IV; de Bruin M; Laan AC; Fukushima M; Peters GJ Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):681-91. PubMed ID: 18600526 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Hotchkiss KA; Ashton AW; Klein RS; Lenzi ML; Zhu GH; Schwartz EL Cancer Res; 2003 Jan; 63(2):527-33. PubMed ID: 12543812 [TBL] [Abstract][Full Text] [Related]
20. Induction of thymidine phosphorylase expression and enhancement of Furtulon sensitivity by Taxol in a human ovarian carcinoma cell line. Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K Anticancer Res; 2003; 23(3B):2665-9. PubMed ID: 12894555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]